Skip to main content
Premium Trial:

Request an Annual Quote

Billie-Jo Kerns, Michael Hogan, Kareem Saad

Premium
Billie-Jo Kerns has been named vice president of strategic marketing and business development at High-Throughput Genomics.
 
Prior to joining HTG, Kerns was the director of integrated solutions and molecular diagnostics at Promega. She also held several positions at Ventana Medical Systems, including director of women's health, director of strategic marketing, and senior director of product technical support in operations. 
 

 
Sigma-Aldrich’s chief administrative officer and chief financial officer Michael Hogan plans to retire sometime this summer, after the company names his successor, Sigma-Aldrich said last week. Hogan said he is leaving the company to pursue volunteer and civic activities. The company has begun a search for his replacement.
 

 
Codon Devices has appointed Kareem Saad to the post of vice president of marketing and business development, a new position at the company. Saad was CEO at Gulfstream Bioinformatics and he was general manager of business development for TransMed Partners, both healthcare IT companies. Saad also held a variety of jobs at IBM, including worldwide business segment executive of R&D and as worldwide solution segment leader of clinical genomics.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.